Inhibitex, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Inhibitex, Inc. - overview

Established

1994

Location

Alpharetta, GA, US

Primary Industry

Pharmaceuticals

About

Founded in 1994 and based in Georgia, US, Inhibitex, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes antibody-based products for the prevention and treatment of fungal and bacterial infections in the hospital setting.


Current Investors

Pacific Horizon Ventures, William Blair Capital Partners, AM Fund

Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Epidemiology, Pharmaceutical Research & Development, Specialty Pharmaceuticals

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Inhibitex, Inc. - financials

Fiscal Year EndedDec 31, 2002Dec 31, 2003Dec 31, 2004Dec 31, 2005Dec 31, 2006Dec 31, 2007Dec 31, 2008Dec 31, 2009Dec 31, 2010
Revenue (USD)-1,095,833650,000936,474-2,803,500---
% Revenue Growth (YoY)--(40.7%)44.1%-----
EBITDA (USD)-(21,884,068)(24,941,580)(38,634,658)-(46,406,520)---
Operating Income (USD)-(22,652,313)(26,444,264)(40,933,499)-(46,083,351)---
Operating Margin-(2067.1%)(4068.3%)(4371.0%)-(1643.8%)---
% EBITDA Margin-(1997.0%)(3837.2%)(4125.5%)-(1655.3%)---
NET Income (USD)-(22,333,021)(25,911,495)(38,575,381)-(41,459,382)---
% Net Margin-(2038.0%)(3986.4%)(4119.2%)-(1478.8%)---

Inhibitex, Inc. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

Inhibitex, Inc. - key contacts

NamePositionStart DateEnd DateVcardBio 
Chairman Of The BoardBM
Member Board of DirectorsBM

BM Board Member

Want to see more?

Request a demo for full access to this profile

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.